Cargando…
Clostridioides difficile infection: microbe-microbe interactions and live biotherapeutics
Clostridioides difficile is a gram-positive, spore-forming, obligate anaerobe that infects the colon. C. difficile is estimated to cause nearly half a million cases in the United States annually, with about 29,000 associated deaths. Unfortunately, the current antibiotic treatment is not ideal. While...
Autor principal: | Wang, Ruojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203151/ https://www.ncbi.nlm.nih.gov/pubmed/37228365 http://dx.doi.org/10.3389/fmicb.2023.1182612 |
Ejemplares similares
-
The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota
por: Zhang, Yongrong, et al.
Publicado: (2022) -
Bacterial Membrane Vesicles as Mediators of Microbe – Microbe and Microbe – Host Community Interactions
por: Caruana, Julie C., et al.
Publicado: (2020) -
Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2023) -
Gnotobiotic Rodents: An In Vivo Model for the Study of Microbe–Microbe Interactions
por: Martín, Rebeca, et al.
Publicado: (2016) -
Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?
por: Nagarakanti, Sandhya, et al.
Publicado: (2023)